Literature DB >> 31671468

[Needs of Patients with Mild Cognitive Disorders in a Specialist Practice].

Jens Bohlken1,2, Anika Rädke3, Thomas Kohlmann4, Steffi Riedel-Heller2, Michael Rapp1.   

Abstract

OBJECTIVE: To describe the needs of care for patients with mild cognitive impairment (PmMCI).
METHODS: Survey of 51 PmMCI in a specialist care practice. Questionnaire based on the CANE assessment scale. Control variables among others are MMST and GDS.
RESULTS: 35 % or 8 % experienced memory disorder as moderate or severe and 27 % or 8 % felt impaired frequently or continuous in everyday life. Over 70 % were in a balanced mood despite the memory problems. Physician-related expectations: follow-up (96 %), dementia risk assessment (73 %), memory training (55 %), drug treatment (33 %). Drug-related expectations: appreciable effect (41 %), willingness to endure side effects (29 %), preference for herbal medication (59 %). Non-drug therapy expectations: athletic activation (63 %), memory training (51 %) and nutritional counselling (37 %). The desire for psychotherapeutic discussions (27 %) was associated with higher depression levels of GDS.
CONCLUSION: PmMCI experienced memory disorder as a burden and impairment. They expected diagnostic and therapeutic support. PmMCI with depressive symptoms expected psychotherapeutic treatment. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2019        PMID: 31671468     DOI: 10.1055/a-1013-0237

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  2 in total

1.  Association Between Ginkgo Biloba Extract Prescriptions and Dementia Incidence in Outpatients with Mild Cognitive Impairment in Germany: A Retrospective Cohort Study.

Authors:  Jens Bohlken; Oliver Peters; Karel Kostev
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

Review 2.  [Memory clinics in Germany-structural requirements and areas of responsibility].

Authors:  Lucrezia Hausner; Lutz Frölich; Christine A F von Arnim; Jens Bohlken; Richard Dodel; Markus Otto; Michael Rapp; Jörg Schulz; Tilmann Supprian; M Axel Wollmer; Frank Jessen
Journal:  Nervenarzt       Date:  2020-10-06       Impact factor: 1.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.